Recent News
Velcura Therapeutics, Inc. Reports Successful Phase 1 Clinical Trial of Novel Bone Disease Therapy
[ more ... ]
President and CEO of Velcura Therapeutics Inc. named the 2008 Grant Thornton Leader and Innovator of the Year
[ more ... ]
Velcura Teams with International Discovery Sourcing Consultants to Develop New Therapeutic Molecules for Cancer and Bone Disease
[ more ... ]